Orchid Advocacy
  • Home
    • About Orchid >
      • Why Orchid?
      • ORCHID'S SYSTEMIC FOCUS & "ROOT CAUSE" ANALYSIS APPROACH TO PROBLEM SOLVING WITH A COMMITMENT TO CREATIVITY & INNOVATION
      • Disclaimers, Limitations and An Invitation
      • Orchid Board
      • Orchid Book Club
      • Conjecture, Science & Translational Research & Medicine
      • Orchid Themes & Symbols
      • The Tipping Point
      • Orchid's Website Advertising Policy
      • Statement for Potential Website Contributors
      • Contact
  • Blogs
    • Val's Blog
    • Val's Blog 2
    • ​TRANSLATIONAL/ ​TRANSITIONAL JUSTICE MONDAY
    • NEURO-DIVERSITY Wednesday
    • Olmstead Law & Order Thursday
    • Translational Medicine Friday
    • Translational Love, Relationships & Neuro-Diversity Saturday
  • Orchid's A-Z Index
    • Crisis Services in CO, the US & Around the World
    • Assertive Community Treatment & Flexible ACT Index
    • Housing & Homelessness Index
    • Criminal Justice
    • Innovation Index
    • For More: See the Main Orchid Index Page
  • US Federal
    • THE IMD RULE & ADMIN. ENFORCEMENT OF DISABILITY CIVIL RIGHTS LAWS
    • Medicaid & Supportive Housing & Housing-Related Services
    • CMS' FAILURE TO COVER HOUSING FOR LTC & THE IMD RULE: WHAT THEY HAVE IN COMMON IS DISCRIMINATION
    • National Take
  • Research & Translational Medicine
    • Immunology & Mental Health >
      • Alcoholism & the Immune System & Mental Health
      • Brain Injury, the Immune System & Mental Health
      • Celiac Disease & Sensitivities, the Immune System & Mental Illness
      • Mental Illness & The Immune System
      • Racial Discrimination & the Immune System & Mental Health
      • Trauma & the Immune System & Mental Health
      • ***Physical Health Issues, the Immune System & Mental Health Index
    • University of Chicago: Institute of Translational Medicine
  • Hot Topics
    • What We Want --- SAMHSA Grant Opportunities Due Jan. 22, 2019
    • Anti-Social Personality Disorder >
      • DECONSTRUCTING ANTISOCIAL PERSONALITY DISORDER AND PSYCHOPATHY: A GUIDELINES-BASED APPROACH TO PREJUDICIAL PSYCHIATRIC LABELS [Hofstra Law Review 2013]
      • Personality Disorders -- Unscientific & Vague -- Must Be Reformed
    • Executive Functioning & "Prison Brain" >
      • Job Accommodation Network on Executive Functioning Deficits
    • Medicaid & Medicare Network Adequacy >
      • OIG: STATE STANDARDS FOR ACCESS TO CARE IN MEDICAID MANAGED CARE (Sept. 2014)
      • OIG: ACCESS TO CARE: PROVIDER AVAILABILITY IN MEDICAID MANAGED CARE (Dec. 2014)
      • GAO 15-710: MEDICARE ADVANTAGE: Actions Needed to Enhance CMS Oversight of Provider Network Adequacy (Aug. 2015)
      • CMS: Promoting Access in Medicaid and CHIP Managed Care: A Toolkit for Ensuring Provider Network Adequacy and Service Availability (April 2017)
    • Medicaid Mental Health & Substance Use Disorder Parity >
      • CMS Parity Compliance Toolkit Applying Mental Health and Substance Use Disorder Parity Requirements to Medicaid and Children’s Health Insurance Programs [Jan. 17, 2017]
      • Frequently Asked Questions: Mental Health and Substance Use Disorder Parity Final Rule for Medicaid and CHIP [CMS October 11, 2017]
    • Olmstead Disability Rights >
      • Statement of the Department of Justice on Enforcement of the Integration Mandate of Title II of the Americans with Disabilities Act and Olmstead v. L.C. (2011)
      • Comprehensive Olmstead Planning
      • the Logical Long Term Consequences of our failure to provide Intensive Community MH Treatment
      • Olmstead Nation ---State Pages: How Far to Comply with Olmstead?
  • Take A Walk Around Orchid's Resource Block
  • Colorado Abuse & Neglect Scandals Involving People with Disabilities
  • Mental Health By The Numbers
  • New Science Is Amazing AND It Has HUGE Moral Implications for Our Society: NOW
  • Olmstead & Homelessness
  • Double V
  • " 'Defund the Police" Means 'Invest in the Resources Our Communities Need' " or Don't Cost Shift to the Police
  • VAGUE OLMSTEAD PLANS, EXPENSIVE LITIGATION
  • Updating & Reforming our Understanding & Treatment of "Anti-Social Personality Disorder" Blog
  • Reform of " Anti-Social Personality Disorder" in Criminal Justice
  • CO HB22-1278
  • New Understandings Matter
  • Mental Health, Ethics & Law
  • CO Olmstead Disability Homeless Law & Policy Project
  • Inflammation, the Immune System, Neuro-Developmental Disorders, Psychiatric Disorders, Substance Use Issues & Chronic Disease
  • Microglia and the Brain's Immune System
  • Substance Issues & the Immune System



Translational Medicine Friday

Cortical Thickness & the Neurobiology of 6 Psychiatric

12/10/2023

 
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders (2021)

JAMA (Journal of the American Medical Assn.) Psychiatry


Conclusions and relevance:   In this study, shared neurobiologic processes were associated with differences in cortical thickness across multiple psychiatric disorders. These processes implicate a common role of prenatal development and postnatal functioning of the cerebral cortex in these disorders.

[See Cleveland Clinic:  Cerebral Cortex]


Affiliations
  • 1 Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • 2 Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada.
  • 3 The Hospital for Sick Children, Toronto, Ontario, Canada.
  • 4 Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • 5 Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles.
  • 6 Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
  • 7 Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • 8 Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • 9 Department of Psychiatry, Yale University, New Haven, Connecticut.
  • 10 Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • 11 University of Groningen, University Medical Center Groningen, Department of Biomedical Sciences of Cells and Systems, Cognitive Neuroscience Center, Groningen, the Netherlands.
  • 12 Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Spain.
  • 13 FIDMAG Germanes Hospitalàries Research Foundation, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Catalonia, Spain.
  • 14 The Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • 15 Department of Pediatrics University of Toronto, Ontario, Canada.
  • 16 Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, Scotland.
  • 17 Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, CIBERSAM.
  • 18 The Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • 19 Social, Genetic and Developmental Psychiatry Centre; Institute of Psychiatry, Psychology and Neuroscience; King's College London, London, England.
  • 20 Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
  • 21 INT UMR 7289, Aix-Marseille Université, CNRS, Aix-en-Provence, France.
  • 22 Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria; Centro de Investigación Biomédica en Red de Salud Mental, Santander, Spain.
  • 23 Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University, the Netherlands.
  • 24 Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
  • 25 Department of Genetics, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • 26 The Research Institute of Pediatrics and Child Health of the Central Clinical Hospital of the Russian Academy of Sciences of the Ministry of Science and Higher Education of the Russian Federation, Moscow, Russia.
  • 27 Magnetic Resonance Image Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • 28 University of Münster, Department of Psychiatry, Münster, Germany.
  • 29 Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.
  • 30 Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy.
  • 31 Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari 'Aldo Moro', Bari, Italy.
  • 32 Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Department of Anatomy & Neuroscience, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • 33 Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Department of Psychiatry, Utrecht, the Netherlands.
  • 34 Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona Bipolar Disorders and Depressive Unit, Hospital Clinic, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
  • 35 Department of Psychiatry, University of Basel, Basel, Switzerland.
  • 36 McLean Hospital, Harvard Medical School, Belmont, Massachusetts.
  • 37 School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.
  • 38 Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
  • 39 Laboratory of Psychiatric Neuroimaging (LIM-21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • 40 Department of Developmental Neuroscience - IRCCS Fondazione Stella Maris, Pisa, Italy.
  • 41 Department of Clinical and Experimental Medicine, University of Pisa.
  • 42 Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State University, Georgia Institute of Technology, Emory University, Atlanta, Georgia.
  • 43 Department of Child and Adolescent Psychiatry and Psychology, Hospital Clinic, Barcelona, Spain.
  • 44 Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM); University of Barcelona, Spain.
  • 45 Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, H91 TK33 Galway, Ireland.
  • 46 School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia.
  • 47 Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • 48 Department of Neuroscience, Brighton and Sussex Medical School, University of Sussex, Brighton, England.
  • 49 Centre for Integrative Neuroscience and Neurodynamics, School of Psychology and Clinical Language Sciences, University of Reading, Reading, England.
  • 50 Departments of Paediatrics and Psychiatry, University of Melbourne, Melbourne, Australia.
  • 51 Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany.
  • 52 Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Santander, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Departamento de Psiquiatria, Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.
  • 53 Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London UK; Zurich Center for Neuroeconomics, University of Zurich, Zurich, Switzerland.
  • 54 Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota.
  • 55 Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, Sackler Institute for Translational Neurodevelopment, London, London, England.
  • 56 Orygen, Melbourne, Australia.
  • 57 Department of Psychiatry, Amsterdam UMC, Amsterdam, the Netherlands.
  • 58 IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • 59 Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada.
  • 60 Department of Psychology, School of Arts and Social Sciences, City, University of London, Northampton Square, Clerkenwell, London, England.
  • 61 Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, Dresden, Germany.
  • 62 Department of Psychiatry and Biological Sciences, Albert Einstein College of Medicine, the Bronx, New York.
  • 63 University Medical Center Goettingen, Department of Psychiatry and Psychotherapy, Systems Neuroscience and Imaging in Psychiatry, Göettingen, Germany.
  • 64 Department of Psychiatry, University of Tuebingen, Tuebingen, Germany.
  • 65 Behavioral Neuroscience Department, Oregon Health & Science University, Portland.
  • 66 Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, New York.
  • 67 Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • 68 Child OCD and Anxiety Disorders Program, Department of Psychiatry, University of Michigan Medical School, Ann Arbor.
  • 69 San Francisco VA Medical Center, San Francisco, California.
  • 70 Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.
  • 71 University of East London, School of Psychology, London, England.
  • 72 Neuroscience Research Australia (NeuRA), Sydney, New South Wales, Australia.
  • 73 Department of Neuroscience, Brighton and Sussex Medical School, Brighton, England.
  • 74 Tommy Fuss Center for Neuropsychiatric Disease Research, Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • 75 Central Clinical Hospital of the Russian Academy Sciences, Moscow, Russia.
  • 76 Department of Psychology, Stanford University, Stanford, California.
  • 77 Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
  • 78 Department of Psychiatry, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • 79 Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • 80 Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University Hospital, Heidelberg, Germany.
  • 81 FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
  • 82 Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • 83 Department of Bioengineering, Imperial College London, London, England.
  • 84 Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • 85 Department of Biomedicine, University of Bergen, Bergen, Norway.
  • 86 Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Melbourne, Victoria, Australia.
  • 87 University of Groningen, University Medical Center Groningen, Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), Groningen, the Netherlands.
  • 88 Department of Experimental Psychology, Vrije Universiteit, Amsterdam, Netherlands.
  • 89 Genentech Inc, South San Francisco, California.
  • 90 Department of Psychology, University of Oslo, Oslo, Norway.
  • 91 Research Center for Child Mental Development, Chiba University, Chiba, Japan.
  • 92 Department of Psychiatry and Weill Institute for Neurosciences, University of California, San Francisco.
  • 93 University of Groningen, University Medical Center Groningen, Department of Child and Adolescent Psychiatry, Groningen, the Netherlands.
  • 94 Radboud University Medical Center, Karakter University Center of Child And Adolescent Psychiatry, Nijmegen, the Netherlands.
  • 95 Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • 96 National Institute of Mental Health, Klecany, Czech Republic.
  • 97 Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • 98 Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
  • 99 Department of Psychiatry and Psychotherapy, Philipps University Marburg, Marburg, Germany.
  • 100 University of Oxford, Oxford, England.




  • 101 Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.
  • 102 Department of Internal Medicine, First Affiliated Hospital of Kunming Medical University, Kunming. China.
  • 103 Research Institute of Pediatrics and child health of the Central clinical hospital of the Ministry of Science and Education, Moscow, Russia.
  • 104 Department of Psychiatry, Philipps-University Marburg, Marburg, Germany.
  • 105 Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
  • 106 Department of Neuroradiology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
  • 107 Child Neuropsychology Section, Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, University Hospital RWTH Aachen, Aachen, Germany.
  • 108 Child Neuropsychology Section, University Hospital RWTH Aachen, German; JARA-Brain Institute II Molecular Neuroscience and Neuroimaging, Research Centre Juelich, Juelich, Germany.
  • 109 Department of Psychiatry and Psychotherapy, University of Bonn, Germany.
  • 110 Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea.
  • 111 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • 112 Mental Health Research Center, Moscow, Russia.
  • 113 Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany.
  • 114 SA MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry, Stellenbosch University, Stellenbosch, South Africa.
  • 115 Institute of Psychiatry, University of Sao Paulo, Sao Paulo, Brazil.
  • 116 Department of Biological and Medical psychology, University of Bergen, Bergen, Norway.
  • 117 Departments of Psychiatry and Pediatrics, University of Calgary, Calgary, Alberta, Canada.
  • 118 University Centre for Information Technology, University of Oslo, Oslo, Norway.
  • 119 Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Australia.
  • 120 Group of Research in Mental Health, Institut d'Investigació Biomèdica Sant Pau, IIBSant Pau; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
  • 121 Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
  • 122 Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • 123 Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
  • 124 McMaster University, Mood Disorders Program, SJH Hamilton, Hamilton, Ontario, Canada.
  • 125 Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
  • 126 Department of Forensic and Neurodevelopmental Science, King's College London, London, England.
  • 127 Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry Psychology and Neuroscience, King's College, London, England.
  • 128 Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston.
  • 129 OCD clinic, Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
  • 130 Department of Pediatrics, University of California, Irvine.
  • 131 Center for MR Research, University Children's Hospital, Zürich, Switzerland.
  • 132 Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • 133 Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Emma Neuroscience Group, department of Pediatrics, Amsterdam Reproduction and Development, Amsterdam, the Netherlands.
  • 134 Center for Neurobehavioral Genetics, University of California Los Angeles.
  • 135 Department of Psychiatry, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • 136 Neuroimaging Unit, Technological Facilities, Valdecilla Biomedical Research Institute IDIVAL; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Santander, Spain.
  • 137 Neuroscience Research Australia, Sydney, Australia.
  • 138 Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, England.
  • 139 Melbourne Neuropsychiatry Centre, University of Melbourne, Melbourne, Australia.
  • 140 Department of Psychology (Biological Psychology, Clinical Psychology, and Psychotherapy), and Center of Mental Health, University of Würzburg, Würzburg, Germany.
  • 141 Division of Child and Adolescent Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland; Child and Adolescent Mental Health Center, Mental Health Services, Capital Region of Denmark, Denmark.
  • 142 Department of Psychiatry and Human Behavior, University of California, Irvine.
  • 143 Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute, Barcelona, Catalonia, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • 144 Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Catalonia, Spain.
  • 145 Priority Centre for Brain & Mental Health Research, The University of Newcastle, Callaghan, New South Wales, Australia.
  • 146 Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Germany.
  • 147 Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • 148 National Institute for Nuclear Physics, Pisa Division, Pisa, Italy.
  • 149 Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England.

  • 150 Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • 151 Center for Depression, Anxiety, and Stress Research, McLean Hospital, Harvard Medical School, Belmont, Massachusetts.
  • 152 Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, Facultad de Psicologia, Universidad Autónoma de Madrid.
  • 153 Neuroscience Research Australia, Sydney, New South Wales, Australia.
  • 154 Department of Child and Adolescent Psychiatry, RWTH Aachen University Hospital, Aachen, Germany.
  • 155 National Human Genome Research Institute and National Institute of Mental Health, Bethesda, Maryland.
  • 156 School of Psychology, Deakin University, Geelong, Melbourne, Australia.
  • 157 West Region, Institute of Mental Health, Singapore.
  • 158 Columbia University Irving Medical Center, New York, New York.
  • 159 Center for Child and Adolescent Mental Health, Institute of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway.
  • 160 Pediatric OCD Consultation Clinic, Anxiety Treatment and Research Center, SJH Hamilton, Ontario, Canada.
  • 161 Department of Psychiatry, New York University School of Medicine, Nathan Kline Institute, New York.
  • 162 Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
  • 163 Anxiety Disorders Center, The Institute of Living, Hartford, Connecticut.
  • 164 Laboratory of Medical Physics and Magnetic Resonance - IRCCS Fondazione Stella Maris, Pisa, Italy.
  • 165 Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.
  • 166 Department of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands.
  • 167 Department of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Centre, Rotterdam, the Netherlands.
  • 168 Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • 169 Academic Child Psychiatry Unit, Department of Pediatrics, University of Melbourne, Royal Children's Hospital, Melbourne, Australia.

  • 170 Hospital Clinic, University of Barcelona, Spain.
  • 171 Department of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Cerdanyola del Vallès, Barcelona, Spain.
  • 172 Instituto ITACA, Universitat Politècnica de València, Valencia, Spain.
  • 173 Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
  • 174 Department for Child and Adolescent Psychiatry, University Hospital RWTH Aachen, Aachen, Germany.
  • 175 Department of Psychology, University of Bath, Bath, England.
  • 176 Clinical Translational Neuroscience Laboratory, University of California Irvine, Irvine, CA; Center for the Neurobiology of Learning and Memory, University of California, Irvine.
  • 177 German Center for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Germany.
  • 178 University of California San Francisco, Department of Psychiatry, Division of Child and Adolescent Psychiatry, University of California, San Francisco, Weill Institute for Neurosciences.
  • 179 Department of Child and Adolescent Psychiatry, New York University Child Study Center, Hassenfeld Children's Hospital at NYU Langone, New York.


  • 180 Seoul National University Hospital, Seoul, Republic of Korea.
  • 181 Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • 182 Departments of Human Genetics and Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
  • 183 Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
  • 184 Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud UMC, Nijmegen, the Netherlands.
  • 185 Donders Centre for Cognitive Neuroimaging, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • 186 Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • 187 Department of Psychiatry, Amsterdam UMC, location VUMC, Amsterdam, the Netherlands.
  • 188 Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.
  • 189 SAMRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
  • 190 Psychology Department and Neuroscience Institute, Georgia State University, Atlanta, Georgia.
  • 191 Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Significant correlation between Altitude and Suicide Mortality among US Veterans

12/9/2023

 
Conjecture

Colorado Medicaid Providers might want to partner in a more STRUCTURED & SYSTEMIC Way to address issues of ALTITUDE and Mental Health with---
  • National Jewish Hospital in Denver
    • They are a national leader in respiratory work & have a SLEEP LAB.
  • My take has been if the COPING MECHANISM you need is OXYGEN ---- THERE REALLY is no SUBSTITUTE.
  • People should be screened for:
    • Deviated Septum
    • Allergies
    • Asthma
    • Sleep Apnea  --- sleep apnea can be due to a lot of things ---
      • Obstructive sleep apnea
      • Substance-Induced sleep apnea, and
      • Altitude induce sleep apnea
        • Sleep apnea has been associated with bipolar disorder according to Taiwan University.
    • Etc.
I re-iterate I don't think the ONLY issue in Mental Health is ALTITUDE, SLEEP APNEA, etc. --- but I think this is an issue that helps explain why Mountainous Regions have significantly above Average Suicide Rates.If we want to say there are other SOCIAL FACTORS --- that's fine --
  • BUT STOP IGNORING ALTITUDE and other Complicated Factors to getting OXYGEN to the BRAIN.
  •  There should be a SYSTEM OF COORDINATED CARE to have people evaluated for oxygen issues and screened for mental health issues. 
I think people can sometimes feel EMBARRASSED by these really MUNDANE ISSUES that could potentially lead to something more SERIOUS or Bizarre Behavior that's even MORE EMBARRASSING or WORSE.
High Altitude & Sky High Suicide Rates
The Need for a New Integrated DSM
Picture
An examination of the association between altitude and suicide deaths, suicide attempts, and suicidal ideation among veterans at both the patient and geospatial level (Sept. 2022)
Highlights

•There is a significant correlation between altitude and suicide mortality rate for U.S. veterans.

•The association between altitude and suicide deaths is higher than the association with suicide attempts or ideation.

•Controlling for relevant factors improves the correlation.
Our work suggested that geospatial factors such as altitude may be significant and should be included in suicide prediction models.

Future studies should incorporate altitude and other hypoxia-related variables into the suicide prediction models in order to further investigate how altitude and associated variables are related to suicide.
Affiliations
  • 1 Applied Mathematics and Computational Research Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
  • 2 Applied Mathematics and Computational Research Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
  • 3 Departments of Mathematics and Statistics, University of California, Los Angeles, CA, USA.
  • 4 Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, USA.
  • 5 Departments of Computer Science, Hood College, Frederick, MD, USA.
  • 6 VISN 4 Mental Illness Research, Education, and Clinical Center, Center of Excellence, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, PA, USA.
  • 7 Durham Veterans Affairs (VA) Health Care System, Durham, NC, USA; VA Mid-Atlantic Mental Illness Research, Education and Clinical Center, Durham, NC, USA; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
  • 8 Durham Veterans Affairs (VA) Health Care System, Durham, NC, USA; VA Mid-Atlantic Mental Illness Research, Education and Clinical Center, Durham, NC, USA; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA; VA Health Services Research and Development Center of Innovation to Accelerate Discovery and Practice Transformation, Durham, NC, USA.
  • 9 Million Veteran Program, Department of Veterans Affairs, USA.

    Translational Medicine Friday

    We're riffing off NPR's Science Friday to create Translational Medicine Friday.

    We'll be collecting Research Article recommendations for Clinicians with regard to Cognitive Disability.

    ​There is much in the RESEARCH JOURNALS and we'll just be SKIMMING THE SURFACE.

    The POINT is to INCREASE FUNDING for TRANSLATIONAL RESEARCH at the Federal Level for the National Institutes of Health, the Centers for Disease Control, the Nation's Research & Teaching Hospitals and possible collaborations with Medicare and Medicaid providers.

    Archives

    April 2025
    March 2025
    February 2025
    January 2025
    December 2024
    November 2024
    October 2024
    September 2024
    August 2024
    July 2024
    June 2024
    May 2024
    April 2024
    March 2024
    February 2024
    January 2024
    December 2023
    October 2023
    September 2023
    August 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021

    Categories

    All

    RSS Feed


Orchid:  Email

Crisis Services in Colorado, the US & Around the World

​Copyright 2025  Orchid Mental Health Legal Advocacy of Colorado, Inc.
Web Hosting by iPage
  • Home
    • About Orchid >
      • Why Orchid?
      • ORCHID'S SYSTEMIC FOCUS & "ROOT CAUSE" ANALYSIS APPROACH TO PROBLEM SOLVING WITH A COMMITMENT TO CREATIVITY & INNOVATION
      • Disclaimers, Limitations and An Invitation
      • Orchid Board
      • Orchid Book Club
      • Conjecture, Science & Translational Research & Medicine
      • Orchid Themes & Symbols
      • The Tipping Point
      • Orchid's Website Advertising Policy
      • Statement for Potential Website Contributors
      • Contact
  • Blogs
    • Val's Blog
    • Val's Blog 2
    • ​TRANSLATIONAL/ ​TRANSITIONAL JUSTICE MONDAY
    • NEURO-DIVERSITY Wednesday
    • Olmstead Law & Order Thursday
    • Translational Medicine Friday
    • Translational Love, Relationships & Neuro-Diversity Saturday
  • Orchid's A-Z Index
    • Crisis Services in CO, the US & Around the World
    • Assertive Community Treatment & Flexible ACT Index
    • Housing & Homelessness Index
    • Criminal Justice
    • Innovation Index
    • For More: See the Main Orchid Index Page
  • US Federal
    • THE IMD RULE & ADMIN. ENFORCEMENT OF DISABILITY CIVIL RIGHTS LAWS
    • Medicaid & Supportive Housing & Housing-Related Services
    • CMS' FAILURE TO COVER HOUSING FOR LTC & THE IMD RULE: WHAT THEY HAVE IN COMMON IS DISCRIMINATION
    • National Take
  • Research & Translational Medicine
    • Immunology & Mental Health >
      • Alcoholism & the Immune System & Mental Health
      • Brain Injury, the Immune System & Mental Health
      • Celiac Disease & Sensitivities, the Immune System & Mental Illness
      • Mental Illness & The Immune System
      • Racial Discrimination & the Immune System & Mental Health
      • Trauma & the Immune System & Mental Health
      • ***Physical Health Issues, the Immune System & Mental Health Index
    • University of Chicago: Institute of Translational Medicine
  • Hot Topics
    • What We Want --- SAMHSA Grant Opportunities Due Jan. 22, 2019
    • Anti-Social Personality Disorder >
      • DECONSTRUCTING ANTISOCIAL PERSONALITY DISORDER AND PSYCHOPATHY: A GUIDELINES-BASED APPROACH TO PREJUDICIAL PSYCHIATRIC LABELS [Hofstra Law Review 2013]
      • Personality Disorders -- Unscientific & Vague -- Must Be Reformed
    • Executive Functioning & "Prison Brain" >
      • Job Accommodation Network on Executive Functioning Deficits
    • Medicaid & Medicare Network Adequacy >
      • OIG: STATE STANDARDS FOR ACCESS TO CARE IN MEDICAID MANAGED CARE (Sept. 2014)
      • OIG: ACCESS TO CARE: PROVIDER AVAILABILITY IN MEDICAID MANAGED CARE (Dec. 2014)
      • GAO 15-710: MEDICARE ADVANTAGE: Actions Needed to Enhance CMS Oversight of Provider Network Adequacy (Aug. 2015)
      • CMS: Promoting Access in Medicaid and CHIP Managed Care: A Toolkit for Ensuring Provider Network Adequacy and Service Availability (April 2017)
    • Medicaid Mental Health & Substance Use Disorder Parity >
      • CMS Parity Compliance Toolkit Applying Mental Health and Substance Use Disorder Parity Requirements to Medicaid and Children’s Health Insurance Programs [Jan. 17, 2017]
      • Frequently Asked Questions: Mental Health and Substance Use Disorder Parity Final Rule for Medicaid and CHIP [CMS October 11, 2017]
    • Olmstead Disability Rights >
      • Statement of the Department of Justice on Enforcement of the Integration Mandate of Title II of the Americans with Disabilities Act and Olmstead v. L.C. (2011)
      • Comprehensive Olmstead Planning
      • the Logical Long Term Consequences of our failure to provide Intensive Community MH Treatment
      • Olmstead Nation ---State Pages: How Far to Comply with Olmstead?
  • Take A Walk Around Orchid's Resource Block
  • Colorado Abuse & Neglect Scandals Involving People with Disabilities
  • Mental Health By The Numbers
  • New Science Is Amazing AND It Has HUGE Moral Implications for Our Society: NOW
  • Olmstead & Homelessness
  • Double V
  • " 'Defund the Police" Means 'Invest in the Resources Our Communities Need' " or Don't Cost Shift to the Police
  • VAGUE OLMSTEAD PLANS, EXPENSIVE LITIGATION
  • Updating & Reforming our Understanding & Treatment of "Anti-Social Personality Disorder" Blog
  • Reform of " Anti-Social Personality Disorder" in Criminal Justice
  • CO HB22-1278
  • New Understandings Matter
  • Mental Health, Ethics & Law
  • CO Olmstead Disability Homeless Law & Policy Project
  • Inflammation, the Immune System, Neuro-Developmental Disorders, Psychiatric Disorders, Substance Use Issues & Chronic Disease
  • Microglia and the Brain's Immune System
  • Substance Issues & the Immune System